BioCardia (BCDA) Net Shares Issued and Repurchased (2016 - 2026)
BioCardia's (BCDA) quarterly Net Shares Issued and Repurchased came in at $30000.0 in Q1 2026, down 90.68% quarter-over-quarter from $321800.0 in Q4 2025.
Powered by 
Analysis
BioCardia (BCDA) Net Shares Issued and Repurchased (2016 - 2026) Analysis & Trends
BioCardia (BCDA) has reported Net Shares Issued and Repurchased for 11 consecutive years, with $30000.0 the latest figure, recorded in Q1 2026.
- On a quarterly basis, Net Shares Issued and Repurchased changed N/A year-over-year to $30000.0 in Q1 2026; TTM through Mar 2026 was $30000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $321800.0, up 2049.06% from the prior year.
- Net Shares Issued and Repurchased was $30000.0 for Q1 2026 at BioCardia, down from $321800.0 in the prior quarter.
- Over five years, Net Shares Issued and Repurchased peaked at $644853.0 in Q4 2022 and troughed at $199.0 in Q1 2023.
- A 5-year average of $161021.4 and a median of $47219.0 in 2023 frame the typical range for Net Shares Issued and Repurchased.
- Across the five-year window, Net Shares Issued and Repurchased sank 99.71% in 2023 and jumped 2049.06% in 2025, its largest moves.
- Over 5 years, Net Shares Issued and Repurchased stood at $644853.0 in 2022, then plunged by 92.68% to $47219.0 in 2023, then tumbled by 68.29% to $14974.0 in 2024, then jumped by 2049.06% to $321800.0 in 2025, then plunged by 90.68% to $30000.0 in 2026.
- The last three Net Shares Issued and Repurchased figures came in at $30000.0 (Q1 2026), $321800.0 (Q4 2025), and $14974.0 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | - |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | - |
| 10 | BioCardia | 13.06 Mn | 8.94 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 30,000.00 |
| Dec 31, 2025 | 321,800.00 |
| Dec 31, 2024 | 14,974.00 |
| Dec 31, 2023 | 47,219.00 |
| Mar 31, 2023 | 199.00 |
| Dec 31, 2022 | 644,853.00 |
| Mar 31, 2022 | 68,105.00 |
| Dec 31, 2021 | 772,435.00 |
| Mar 31, 2021 | 44,643.00 |
| Dec 31, 2020 | 342,232.00 |
| Mar 31, 2020 | 31,455.00 |
| Dec 31, 2019 | 254,785.00 |
| Dec 31, 2018 | 1.70 Mn |
| Mar 31, 2018 | 1.43 Mn |
| Dec 31, 2017 | 842,653.00 |
| Mar 31, 2017 | 4.41 Mn |
| Dec 31, 2016 | 32.18 Mn |